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In 2011, a Shiga toxin-producing Enteroaggregative Escherichia coli (EAEC Stx2a+)
O104:H4 strain caused a serious outbreak of acute gastroenteritis and hemolytic-
uremic syndrome (HUS) in Germany. In 2013, E. coli O104:H4 isolates were obtained
from a patient with HUS and her friend showing only gastrointestinal complaints. The
antimicrobial resistance and virulence profiles of these isolates together with three EAEC
Stx2a+ O104:H4 isolates from 2011 were determined and compared. Whole-genome
sequencing (WGS) was performed for detailed characterization and to determine genetic
relationship of the isolates. Four additional genomes of EAEC Stx2a+ O104:H4 isolates
of 2009 and 2011 available on NCBI were included in the virulence and phylogenetic
analysis. All E. coli O104:H4 isolates tested were positive for stx2a, aatA, and terD but
were negative for escV. All, except one 2011 isolate, were positive for aggR and were
therefore considered EAEC. The EAEC Stx2a+ O104:H4 isolates of 2013 belonged to
sequence type (ST) ST678 as the 2011 isolates and showed slightly different resistance
and virulence patterns compared to the 2011 isolates. Core-genome phylogenetic
analysis showed that the isolates of 2013 formed a separate cluster from the isolates of
2011 and 2009 by 27 and 20 different alleles, respectively. In addition, only a one-
allele difference was found between the isolate of the HUS-patient and that of her
friend. Our study shows that EAEC Stx2a+ O104:H4 strains highly similar to the 2011
outbreak clone in their core genome are still circulating necessitating proper surveillance
to prevent further outbreaks with these potentially pathogenic strains. In addition, WGS
not only provided a detailed characterization of the isolates but its high discriminatory
power also enabled us to discriminate the 2013 isolates from the isolates of 2009
and 2011 expediting the use of WGS in public health services to rapidly apply proper
infection control strategies.
Keywords: Shiga toxin-producing E. coli –STEC, enterohemorrhagic E. coli –EHEC, hemolytic uremic syndrome,
outbreak, antimicrobial resistance, whole genome sequencing, phylogenetic analysis
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INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) are a pathogenic
group of Escherichia coli (E. coli) producing the potent cytotoxin
Shiga-toxin (Stx) similar to the one produced by Shigella
dysenteriae serotype 1 (Gyles, 2007). STEC may cause a broad
spectrum of illness, ranging from diarrhea to the potentially
fatal hemolytic uremic syndrome (HUS) (Farrokh et al., 2013).
A subset of STEC can cause bloody diarrhea in humans and
they are known as enterohemorrhagic E. coli (EHEC) while
a subset of EHEC can cause HUS and are known as HUS-
associated E. coli HUSEC (Mellmann et al., 2008). In addition
to Shiga toxin-converting bacteriophages, STEC may contain
several other mobile genetic elements encoding virulence factors
as pathogenicity islands (PAI), and a large, approximately 90 kb
plasmid (pO157; Karch, 2001). Stx production is common to
all HUS-associated E. coli isolates regardless of their serotype.
When the toxin enters the blood stream it binds to receptors on
endothelial cells abundantly present in kidneys and brain, leading
to neurological sequel and/or to microvascular disease that may
result in HUS (Welinder-Olsson and Kaijser, 2005).
In 2011, a large outbreak was reported in Germany
caused by an Enteroaggregative E. coli (EAEC) O104:H4
strain lysogenized with the Stx2a bacteriophage and thereby
becoming an EAEC/STEC hybrid strain (Bielaszewska et al.,
2011; Brzuszkiewicz et al., 2011). Besides the stx2a gene, this
unusual strain had virulence properties of EAEC including
plasmid pAA carrying the aggregative adherence ﬁmbriae
(AAF) variant I encoded by the aggA gene whose expression
is regulated by the aggR gene. In addition, it contained a
protein-coat secretion system (Aat), dispersin (Aap), a putative
type VI secretion system (Aai), and a rare combination of
serine protease autotransporters of Enterobacteriaceae (SPATEs)
genes, i.e., sepA, sigA, and pic (Rasko et al., 2011; Scheutz
et al., 2011). It also contained a terD gene (tellurite resistance
gene as a marker for the ter cluster) and a plasmid-borne
extended spectrum beta-lactamase (ESBL) gene blaCTX−M−15
resulting in resistance to several antibiotics (Brzuszkiewicz
et al., 2011; Rasko et al., 2011). However, the outbreak clone
did not possess the escV gene encoding the predicted outer
membrane protein and a marker for the locus of enterocyte
eﬀacement (LEE) PAI (Müller et al., 2009; Scheutz et al.,
2011).
In clinical microbiology, whole genome sequencing (WGS)
has already shown its value in outbreak investigations and
epidemiological typing due to its high-resolution discriminatory
power and detailed virulence proﬁling, thereby becoming more
and more important in routine diagnostics (Mellmann et al.,
2011; Rohde et al., 2011; Grad et al., 2012). In this study, we
characterized EAEC Stx2a+ O104:H4 strains isolated from a
HUS patient and her friend who traveled together to Turkey
in 2013 prior to diagnosing the patient with HUS. For this, a
WGS approach in parallel with routine phenotypic and genotypic
laboratory methods was used. Analyses were performed to get
more insight into the antibiotic resistance and virulence proﬁles
of the isolates and to reveal their genetic relationship with the
2011 German outbreak EAEC Stx2a+ O104:H4 isolates.
MATERIALS AND METHODS
E. coli Isolates used in This Study
In July 2013, four E. coli isolates were obtained from a HUS
patient (isolate 338) and her friend (isolates 381-1, 381-3, and
381-4). They were compared to three EAEC Stx2a+ O104:H4
strains named 7N, 8G, and LB227103 which were a kind gift
of Dr. Alexander Mellmann (Institute of Hygiene, University
of Muenster, Muenster, Germany) and were isolated during the
2011 German outbreak period from stool samples of patients,
submitted to the National Consulting Laboratory for HUS
in Münster, Germany, between May 23 and June 2, 2011
(Bielaszewska et al., 2011; Pritchard et al., 2012). In addition,
publically available genomes of ﬁve previously reported strains
(TY-2482, 2011C-3494, 2009EL-2050, 2009EL-2071, and 55989)
were included in virulence and phylogenetic analyses. Detailed
information on the isolates used in this study is shown in Table 1.
Diagnostic Procedures
Fecal samples from the HUS patient (patient 338) and her
friend (patient 381) were collected for diagnostic purposes at
Certe Laboratory for Infectious Diseases as described previously
(de Boer et al., 2015). Shortly, fecal samples were screened for
the presence of the virulence genes stx1, stx2, and escV by real-
time PCR (qPCR) and stx-positive samples were subsequently
enriched in Brilliant green bile (BGB) broth. After DNA isolation
from the enriched broth, qPCR was performed for detection of
the EAEC pAA plasmid encoding genes aggR and aatA, and
O-serogroup encoding genes (O26, O91, O103, O104, O111,
O121, O145, and O157). In parallel, part of the BGB broth
was plated on CHROMagar STEC and Sorbitol MacConkey
agar plates (Mediaproducts BV, Groningen, the Netherlands). To
obtain a pure isolate from the selective agar plates, more than
30 colonies of each patient were analyzed for the presence of
stx genes by qPCR and for ESBL production by using CHROM
ID ESBL agar (bioMérieux, Marcy I’Etoile, France). In addition,
sorbitol fermentation and tellurite resistance of the isolates were
determined by observing their ability to grow on CT-SMAC
plates (Sorbitol MacConkey agar with Ceﬁxime and Tellurite).
In addition, conventional PCRs for stx-subtypes 2a, 2b, 2c, 2d,
2e, 2f, and 2g were performed to determine the subtype of
the stx2 gene as described previously (Scheutz et al., 2012).
Finally, a multiplex PCR targeting typical molecular features
of the 2011 outbreak strain, i.e., the presence of the wzyO104
(O antigen polymerase as a marker for the E. coli O104 gene
cluster), fliCH4 (encoding the H4 speciﬁc ﬂagellin), stx2, and
terD genes was performed (Bielaszewska et al., 2011; Zhang et al.,
2012).
Antimicrobial Resistance
Antibiotic resistance patterns of the four isolates of 2013 (338,
381-1, 381-3, and 381-4) and three isolates of 2011 (7N,
8G, and LB227103) were analyzed using VITEK2 (bioMerieux,
Marcy l’Etoile, France) and E-Test (bioMérieux, Marcy l’Etoile,
France) following EUCAST guidelines. Presence of ESBL,
carbapenemases and AmpCs genes was conﬁrmed using the
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TABLE 1 | Characteristics of isolates analyzed in this study.
Isolate ID Date of
isolation
Country of
isolation
Clinical
manifestations
stx
subtype
Serotype Extended spectrum
beta-lactamase
(ESBL)
Multilocus
sequence typing
(MLST)
Source
338 July 2013 Netherlands HUS 2a O104:H4 Negative ST-678 This study
381-1 July 2013 Netherlands Diarrhea 2a O104:H4 Positive ST-678 This study
381-3 July 2013 Netherlands Diarrhea NAa O126:H2 Positive ST-10 This study
381-4 July 2013 Netherlands Diarrhea 2a O104:H4 Negative ST-678 This study
7N 2011 Germany Unknown 2a O104:H4 Positive ST-678 This study
8G 2011 Germany Unknown 2a O104:H4 Positive ST-678 This study
LB227103 2011 Germany HUS 2a O104:H4 Positive ST-678 Bielaszewska et al.,
2011; Pritchard
et al., 2012
TY-2482 2011 Germany HUS 2a O104:H4 Positive ST-678 Rohde et al., 2011
2011C-3493 2011 USA HUS 2a O104:H4 Positive ST-678 Ahmed et al., 2012
2009EL–2050 2009 Republic of
Georgia
Bloody diarrhea 2a O104:H4 Negative ST-678 Ahmed et al., 2012
2009EL–2071 2009 Republic of
Georgia
Bloody diarrhea 2a O104:H4 Negative ST-678 Ahmed et al., 2012
55989 1995 Central
African
Republic
Diarrhea NAa O104:H4 Negative ST-678 Touchon et al.,
2009; Miko et al.,
2013
aNA = Not applicable as these isolates are stx negative.
Check-MDR CT103 assay according to the manufacturer’s
protocol (Check-Points BVWageningen, the Netherlands).
DNA Isolation
For repetitive sequence based PCR ﬁngerprinting and WGS,
genomic DNA was extracted by the UltraClean R© microbial
DNA isolation kit (MO BIO Laboratories, Carlsbad, CA,
USA) according to the manufacturer’s protocol. For other
molecular assays DNA was extracted using a DNeasy blood and
tissue kit (QIAGEN, GmbH, Hilden, Germany) following the
manufacturer’s protocol.
Multilocus Sequence Typing (MLST)
Multilocus sequence typing was performed using a 3130xl
Genetic Analyzer (Applied Biosystems) to sequence internal
fragments of seven housekeeping genes (adk, fumC, gyrB, icd,
mdh, purA, and recA) according to the protocol described
in the E. coli MLST databases (http://mlst.warwick.ac.uk/
mlst/dbs/Ecoli/documents/primersColi_html). The alleles and
sequence types (ST) were assigned in accordance with the same
database.
Virulence Properties
To assess the presence of known E. coli virulence genes, a DNA
microarray analysis was performed using the E. coli genotyping
combined assay kit according to the manufacturer’s protocol
(Clondiag, Alere Technologies, GmbH, Jena, Germany; Geue
et al., 2010).
Repetitive Sequence based PCR
(rep-PCR)
Isolated DNA was ampliﬁed using the DiversiLab Escherichia kit
for repetitive sequence based PCR ﬁngerprinting following the
manufacturer’s instructions (bioMérieux, Marcy-l’Etoile, France).
The rep-PCR products were detected and analyzed using lab-on-
a-chip microﬂuidics technology on an Agilent 2100 Bioanalyzer
(Agilent, Santa Clara, CA, USA). Further analysis was performed
with the web-based DiversiLab software (version 3.4) using the
Pearson correlation coeﬃcient to calculate pairwise similarities
among all samples. In this study, we used 95% similarity
thresholds for the data analysis (Voets et al., 2013).
Whole Genome Sequencing and Analysis
A DNA library was prepared using the Nextera XT kit
(Illumina, San Diego, CA, USA) according to the manufacturer’s
instructions and then run on a Miseq (Illumina) for generating
paired-end 250-bp reads. De novo assembly was performed
using default settings of CLC Genomics Workbench v6.0.5
(CLC bio A/S, Denmark) as described previously (Ferdous
et al., 2015). The MLST ST was also conﬁrmed from the
whole genome sequence by uploading the assembled genomes
to the CGE MLST server (version 1.7; Larsen et al., 2012);
the conﬁguration for MLST was set to E. coli scheme 1. The
resistome was generated by uploading assembled genomes to
the CGE Resﬁnder server 2.0 (Zankari et al., 2012). The default
settings for Resﬁnder were used except for the threshold of
ID that was set to 85%. The serogenotype of the isolates was
identiﬁed using CGE SerotypeFinder 1.0 (Joensen et al., 2015).
The virulence genes were identiﬁed by mapping reads to a
pseudomolecule generated by concatenating a set of E. coli
virulence genes described before (Bielaszewska et al., 2011; Lima
et al., 2013). In addition to the isolates of 2013 and 2011, the
genomes of two isolates of 2009 (2009EL-2050, 2009EL-2071)
were included for comparison of the virulence genes. The genome
sequence of 2011C-3493 (GenBank accession no. NC_018658.1)
was used as reference for extracting open reading frames (ORFs)
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from contigs of each strain by SeqSphere v1.0 (Ridom GmbH,
Münster, Germany). Only the ORFs without premature stop
codons and ambiguous nucleotides were extracted, and the
sequences of those ORFs shared by all samples analyzed here
were deﬁned as the core genome for subsequent phylogenetic
analysis (Leopold et al., 2014). According to the sequence
identity of each ORF, a numerical allele type was assigned by
SeqSphere. SeqSphere used the allelic proﬁle formed by the
combination of all alleles in each genome for constructing the
minimum-spanning tree. This Whole Genome Shotgun project
has been deposited at DDBJ/EMBL/GenBank under the accession
number JRJF01000000 (E. coli 338), JRKD01000000 (E. coli
381-1), JRLM01000000 (E. coli 381-3), JRLD01000000 (E. coli
381-4), JRKE01000000 (E. coli 7N), JRLN00000000 (E. coli 8G),
JRKF01000000 (E. coli LB227103). The version described in this
paper is the ﬁrst version.
RESULTS
Demographic and Clinical
Characteristics of Patients
Strain 338 was isolated from the fecal sample of a 22 year-
old female patient (338) admitted to the Intensive Care Unit
of the University Medical Center Groningen (UMCG) in July
2013, after returning from a holiday in Turkey. She presented
with abdominal pain, bloody diarrhea, vomiting, and eventually
developed HUS. Patient 381, a 24-year-old female traveling
together with patient 338, showed symptoms of diarrhea,
abdominal cramps, and abdominal pain but was not hospitalized.
Primary Screening Results
Direct screening of feces by qPCR revealed the presence of
stx1, stx2, and escV genes (patient 338) and stx2 gene (patient
381). Additional molecular screening of DNA isolated from
enriched BGB broth for other virulence genes and O-serogroups
resulted in detection of aggR, aatA, and wzyO104 in both patients.
Subsequently, as a result of colony screening for the presence of
the stx gene and/or for ESBL production one stx2-positive non-
ESBL-producing isolate (isolate 338) was obtained from patient
338, whereas two diﬀerent stx2-positive isolates were recovered
from patient 381: an ESBL producing isolate (381-1) and a non-
ESBL producing isolate (381-4). In addition, one stx-negative but
ESBL-producing isolate (381-3) was obtained from this patient.
All stx-positive isolates contained the aatA and terD but not
the escV gene, similar to the 2011 German outbreak isolates.
No stx1-positive isolates were obtained. The aggR gene was
detected in the 2013 and two of the three 2011 isolates (7N and
8G) but unexpectedly not in isolate LB227103. All stx-positive
isolates were subtyped as stx2a and shared the same serotype
(O104:H4) as the 2011 German outbreak isolates, whereas the
stx negative ESBL producing isolate was serotype O126:H2. All
isolates were sorbitol fermenting and tellurite resistant. MLST
analysis showed that all 2013 EAEC Stx2a+ O104:H4 isolates
belonged to ST678 as the 2011 outbreak strains, whereas the
stx-negative isolate (381-3) was assigned to ST10. The screening
results are summarized in Table 1.
Phenotypic and Genotypic Resistance
Profiles
Isolates 338 and 381-4 (both ESBL negative) were resistant
to ampicillin and trimethoprim. Isolate 381-1 (ESBL positive)
was resistant to ampicillin, cefotaxime, ceftazidime, cefepime,
cefuroxime, and trimethoprim and this resistance pattern
was almost identical to that of the stx-negative/ESBL
positive isolate 381-3 from the same patient except that
the latter was susceptible to trimethoprim. The resistance
pattern of isolate 381-1 diﬀered from that of three of the
2011 outbreak isolates which were resistant to amoxicillin-
clavulanic acid, tetracycline and trimethoprim/sulfamethoxazole
(Table 2).
In agreement with the results of the phenotypic resistance
pattern, the resistome of the three 2013 EAEC Stx2a+ O104:H4
TABLE 2 | Phenotypic antibiotic resistance patterns and presence of corresponding antibiotic resistance genes among the isolates.
Isolates analyzed in this study (Phenotype/Presence of corresponding gene)
2011 isolates 2013 isolates
Name of Antibiotics 7N 8G LB227103 338 381-1 381-4 381-3
Ampicillin R/blaTEM−1 R/blaTEM−1 R/blaTEM−1 R/blaTEM−1 R/blaTEM−1 R/blaTEM−1 R/blaTEM−1
Amoxicillin+ Clav acid R/blaTEM−1 R/blaTEM−1 R/blaTEM−1 S I S S
Cefuroxime R/blaCTX−M−15 R/blaCTX−M−15 R/blaCTX−M−15 S/N R/blaCTX−M−15 S/N R/blaCTX−M−15
Cefotaxime R/blaCTX−M−15 R/blaCTX−M−15 R/blaCTX−M−15 S/N R/blaCTX−M−15 S/N R/blaCTX−M−15
Ceftazidime R/ blaCTX−M−15 R/ blaCTX−M−15 R/ blaCTX−M−15 S/N R/ blaCTX−M−15 S/N R/blaCTX−M−15
Cefepime R/blaCTX−M−15 R/blaCTX−M−15 R/blaCTX−M−15 S/N R/blaCTX−M−15 S/N R/blaCTX−M−15
Co-trimoxazole R/sul1 & 2 R/sul1 & 2 R/sul1 & 2 S/sul1a S/sul1a S/sul1a S/N
Tetracycline R/tetA R/tetA R/tetA S/N S/N S/N S/N
Trimethoprime R/dfrA7 R/dfrA7 R/dfrA7 R/dfrA7 R/dfrA7 R/dfrA7 S/N
Streptomycin ND/strA-B ND/strA-B ND/strA-B ND/N ND/N ND/N ND/N
(R, represents drug resistance; S, represents drug sensitivity; I, represents intermediate; N, represents not found; ND, represents not determined).
asul1 gene was deactivated by an IS26 insertion.
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TABLE 3 | Virulence genes detected by qPCR, microarray and whole-genome sequencing (WGS) analysis.
Gene name Function 7N 8G LB227103 338 381-1 381-4 2009EL-2050 2009EL-2071 55989
aapa Synthesis of anti-aggregation protein
dispersin
+ + + + + + + + +
aatA Necessary for translocation of dispersin
(Aap)
+ + + + + + + + +
aaiCa aggR-activated island C + + + + + + + + +
aggAa (AAF/I) Pilin subunit of aggregative adherence
fimbriae I
+ + + + + + + + −
aafAa Pilin subunit of aggregative adherence
fimbriae II
− − − − − − − − −
agg3Aa (AAF/III) Pilin subunit of aggregative adherence
fimbriae III
− − − − − − − − +
agg4Aa Pilin subunit of aggregative adherence
fimbriae IV
− − − − − − − − −
Agg5Aa Pilin subunit of aggregative adherence
fimbriae V
− − − − − − − − −
aggR Transcriptional regulator AggR + + − + + + + + +
astA (EAST1) heat-stable enterotoxin 1 − − − − − − − − +
bfpA Bundle-forming pili − − − − − − − − −
cdt (I-V) Cytolethal distending toxin − − − − − − − − −
eae Intimin − − − − − − − − −
EHEC-hlyA EHEC haemolysin − − − − − − − − −
elt Heat-labile enterotoxin (LT) − − − − − − − − −
espP Serine protease − − − − − − − − −
est1a Heat-stable enterotoxin (STIa) − − − − − − − − −
est1b Heat-stable enterotoxin (STIb) − − − − − − − − −
fyuAa Component of iron uptake system on
HPI
+ + + + + + + + +
iala Invasive plasmid (pInv) − − − − − − − − −
iha Iron-regulated gene + + + + + + + + +
irp2a Component of iron uptake system on
HPI
+ + + + + + + + +
lpfAO113a Structural subunit of LPF of STEC O113 + + + + + + + + +
lpfAO157−OI141a Structural subunit of LPF of STEC
O157:H7
− − − − − − − − −
lpfAO157−OI154a Structural subunit of LPF of STEC
O157:H7
− − − − − − − − −
lpfAO26a Structural subunit of long polar fimbriae
(LPF) of STEC O26
+ + + + + + + + +
mchB Synthesis of Microcin + + + − − − + + −
mchC Synthesis of Microcin + + + − − − + + −
mchF Synthesis of Microcin + + + + + + + + −
pet Plasmid-encoded toxin − − − − − − − − −
pic Gene encoding protein for intestinal
colonization
+ + + + + + + + +
saa STEC autoagglutinating adhesin − − − − − − − − −
sat Secreted autotransporter toxin − − − − − − − − −
set1a Shigella enterotoxin 1 + + + + + + + + +
sepA Shigella extracellular protease + + + + + + + + -
sfpA Plasmid-borne gene encoding the pilin
subunit
− − − − − − − − −
sigA Shigella IgA-like protease homolog + + + + + + + + +
stx1 Shiga toxin 1 − − − − − − − − −
stx2 Shiga toxin 2 + + + + + + + + −
subA Subtilase cytotoxin − − − − − − − − −
ter cluster Tellurite resistance + + + + + + + + −
aData derived only from WGS.
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FIGURE 1 | Dendrogram of Escherichia coli isolates based on rep-PCR
results. Stx2a+ O104:H4 isolates of 2011 and 2013 are separated into two
clusters with a similarity of less than 95% whereas the non O104:H4 E. coli
isolates are clearly separated with a similarity of less than 80%.
isolates diﬀered from that of the 2011 isolates: the strA,
strB (streptomycin resistance), sul2 (sulfonamide resistance),
and tetA (tetracycline resistance) genes were only found
in the 2011 outbreak isolates (Table 2). A blaCTX−M−15
gene was detected in isolate 381-1 (stx-positive) and 381-3
(stx-negative) as well as in the 2011 isolates. In addition,
WGS showed the presence of the dfrA7 gene in all isolates
except 381-3 resulting in the latter’s trimethoprim-sensitive
phenotype. A truncated sul1 gene resulting from an
insertion of IS26 was found in all EAEC Stx2a+ O104:H4
isolates.
Virulence Profile
DNA microarray results showed that the virulence proﬁle of the
2013 isolates was similar to that of the EAEC Stx2a+ O104:H4
isolates of 2011 and 2009 used in this study. The only diﬀerence
was the presence of the microcin H47 biosynthesis gene mchB
and mchC, which were identiﬁed in the 2009 and 2011 strains,
but were absent in the EAEC Stx2a+ O104:H4 isolates of 2013.
The results obtained byWGSwere identical to that of the DNA
microarray and conﬁrmed the absence of the aggR gene in the
outbreak strain LB227103. WGS revealed the presence of several
additional virulence genes including aap, aaiC, aggA, lpfAO113,
lpfAO26, fyuA, irp2, and set1 (not detected by PCR or microarray)
in our isolates (Table 3).
Phylogenetic Analyses
Rep-PCR analysis was used to investigate the genetic relationship
between the diﬀerent isolates. EAEC Stx2a+ O104:H4 isolates
of 2011 and 2013 clustered into two diﬀerent groups sharing
a similarity of less than 95% whereas the two non O104:H4
isolates (E. coliATCC 25922 and E. coliO126:H2) separated from
the O104:H4 clusters with less than 80% similarity (Figure 1).
To type the diﬀerent isolates with an even higher resolution,
a core-genome phylogenetic analysis based on WGS results
was performed. In total 3764 ORFs were shared by all isolates
analyzed and these were deﬁned as the core genome for further
phylogenetic analysis in this study. The minimum-spanning
tree shows that the three 2013 EAEC Stx2a+ O104:H4 isolates
clustered together with one to two-allele diﬀerence among them.
One-allele diﬀerence of isolate 381-1 from isolates 338 and 381-4
was found in the gene encoding a carboxyterminal protease and
was caused by a non-synonymous point mutation (1481T > A)
resulting in a premature protein (Leu494Stop) in isolate 381-1. In
addition, one-allele diﬀerence of isolate 381-4 from isolates 338
and 381-1 was found in a gene encoding a putative cation:proton
antiport protein caused by a non-synonymous point mutation
(1465A > C) resulting in an amino-acid change in the protein
(Ile489Leu) in isolate 381-4. No allele diﬀerences were found
between the three 2011 outbreak isolates (7N, 8G, and LB227103),
and they clustered together with two other reported outbreak
strains (TY-2482 and 2011C-3493) with two to three-allele
diﬀerence among them (Figure 2). The 2009 isolates (2009El-
2071 and 2009El-2050) were separated from each other with
a ﬁve-allele diﬀerence. The cluster of 2013 O104:H4 isolates
were separated from the 2009 and 2011 O104:H4 clusters with
a minimum of 20 and 27 diﬀerent alleles, respectively (Figure 2
and Supplementary Table S1). There weremore than 193 diﬀerent
alleles between the typical EAEC strain 55989 (O104:H4 stx-
negative) and the 2013 EAEC stx2a+ O104:H4 isolates, whereas
isolate 381-3 (O126:H2, stx-negative) was far distinct from any
of the O104:H4 strains analyzed, with more than 3291-allele
diﬀerences (Figure 2).
DISCUSSION
In this study, EAEC Stx2a+ O104:H4 isolates obtained from
stool samples of a HUS patient and her friend, traveling together
to Turkey in 2013, were characterized and compared with the
2011 German EAEC Stx2a+ O104:H4 outbreak isolates and with
two isolates from cases of bloody diarrhea that occurred in
the Republic of Georgia in 2009. The phylogenetic relationship
of these isolates was also compared with EAEC 55989, the
hypothetical EAEC Stx2a+ O104:H4 progenitor strain isolated
in central Africa in 1995. Besides using established molecular
typing methods routinely used in our laboratory, WGS was
used. Initially, the three EAEC Stx2a+O104:H4 isolates obtained
in 2013 were suspected to be similar to the 2011 German
outbreak strains based on PCR results. The 2013 isolates could
not be distinguished from the 2011 outbreak strains using a
multiplex screening PCR targeting O104wzy, fliCH4, stx2, and
terD genes as characteristic features of the 2011 outbreak strains
(Bielaszewska et al., 2011; Zhang et al., 2012). Our microarray
analyses revealed more detailed information but did not allow
us to deﬁnitely discriminate the 2013 EAEC Stx2a+ O104:H4
isolates from the 2011 ones. Diﬀerences found between the
2011 and 2013 EAEC Stx2a+ O104:H4 isolates included two
virulence genes (mchB andmchC) and three drug-resistant genes
(tetA, strA-B, and sul2). However, these genes are known to
be located in multiple genomic islands and could therefore be
easily lost or obtained (Grad et al., 2013; Guy et al., 2013).
Although rep-PCR separated the 2011 and 2013 EAEC Stx2a+
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FIGURE 2 | Core-genome phylogenetic analysis of E. coli strains. The minimum spanning tree was generated by SeqSphere and based on allelic profiles
comparing 3764 alleles present in all analyzed strains and defined as their core genome. Numbers in the lines indicate the number of allele differences between
isolates. Black lines indicate minimum distances and red lines connect isolates with more than minimum distances. Different colors represent isolates of different time
periods except isolate 381-3, which was isolated in 2013 but marked in a different color as it is stx negative. EAEC 55989 was used as the hypothetical EAEC
Stx2a+ O104:H4 progenitor.
O104:H4 isolates into two clusters, this technique is not suitable
for large-scale/global outbreak typing, as the inter-laboratory
reproducibility is not suﬃcient for this. In addition, also the
intra-laboratory reproducibility may vary making it necessary
for an accurate typing to include all the isolates that need to be
compared within the same run (Voets et al., 2013). The high
resolution of WGS enabled us to discriminate the 2013 isolates
from the 2011 German outbreak in the most accurate way.
In this study, a gene-by-gene typing approach also known
as whole genome MLST (wgMLST), extended MLST, MLST+
or core genome MLST (cgMLST) was used (Maiden et al.,
2013). The EAEC Stx2a+ O104:H4 isolates of 2013 appear
to diﬀer from those of 2011 and 2009 by a minimum of 27
and 20 alleles, respectively. This suggests that 2013 isolates
were relatively closer related to the 2009 clone of southeast
Europe than to the 2011 outbreak clone. Unfortunately, there
is no established threshold for the MLST+ approach to address
intra- and inter-cluster diﬀerences yet. In addition, only the
core genome was used for constructing the phylogenetic tree
minimizing the chance of including mobile genetic elements
(MGEs) in the analysis as there is no consensus on how MGEs
should be taken into account in bacterial phylogeny (Daubin
et al., 2002; Frost et al., 2005). As the estimated mutation rate
of E. coli is reported to be 1.1 nucleotide per genome per
year (Reeves et al., 2011), the 27-allele diﬀerence between the
2013 and 2011 isolates suggests that the EAEC Stx2a+ O104:H4
isolates from the diﬀerent time periods belong to diﬀerent clones.
Moreover, only a one-allele diﬀerence was found between the
isolate of the HUS patient and that of her friend, strongly
supporting the hypothesis that either both patients obtained
STEC from the same source or that one transmitted STEC to the
other.
In addition to high resolution typing, WGS provided us
with more detailed molecular characteristics of the isolates. This
helped us to explain in more detail the phenotypic results of
the isolates. For example, an insertion within the sul1 gene
resulting in protein truncation was found in all 2013 EAEC
Stx2a+ O104:H4 isolates, which could explain why the isolates
were susceptible to trimethoprim/sulfamethoxazole in spite of the
presence of the sul1 gene detected by the microarray. On the other
hand, a sul2 gene existing in the 2011 but not the 2013 isolates
may confer resistance to trimethoprim/sulfamethoxazole in spite
of the fact that also the 2011 isolates carried the truncated sul1.
Notably, one of the 2013 EAEC Stx2a+ O104:H4 isolates
(381-1) was blaCTX−M−15 positive as the 2011 outbreak isolates.
As isolate 381-3 (stx-negative/O126:H2/blaCTX−M−15) was also
obtained from the same host, it is likely that 381-1 acquired this
ESBL gene from isolate 381-3 or the other way around. Our study
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did, however, not address a detailed analysis of the MGEs and
plasmids as the aim of the study was to show the value of WGS
technique in routine clinical diagnostics to identify and compare
potentially pathogenic strains.
Recently, two similar isolates of EAEC Stx2a+ O104:H4
causing bloody diarrhea and HUS were reported in Belgium.
Patients of both cases traveled to Tunisia and Turkey,
respectively, and the infection may have been acquired in those
regions (De Rauw et al., 2014). This is similar to our and other
studies describing EAEC Stx2a+ O104:H4 infections associated
with traveling to Turkey, Tunisia, Egypt, and North Africa
(Ecdc/Efsa, 2011; Grad et al., 2013).
Our study shows that WGS has the potential to be
integrated in current routine laboratories to relatively
rapidly obtain reproducible and detailed information in
one single step. This facilitates hospitals and public health
organizations to make appropriate strategies for infection
control and public health measures in real time (Reuter et al.,
2013). Surely, some challenges have to be overcome before
applying WSG to routine diagnostics, like the availability
of user-friendly bioinformatics tools, automation of the
workﬂow and availability of genomic databases (Sherry et al.,
2013).
CONCLUSION
The detailed characterization of EAEC Stx2a+ O104:H4
isolates obtained in 2013 including the high resolution typing
approach helped us to distinguish them from the 2011
German outbreak strains. It further supported the general idea
that, although the 2011 outbreak is stopped, EAEC Stx2a+
O104:H4 strains highly similar to the 2011 outbreak strain
in their core genome still circulate. They still pose a serious
risk for public health being a potential source for causing
a new EAEC Stx2a+ O104:H4 outbreak if not monitored
carefully.
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